KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention and Prevention of Chronic Kidney Disease-Mineral and Bone Disorder (CKDMBD): Indian Commentary

Overview

Journal Indian J Nephrol

Specialty Nephrology

Date 2020 Dec 4

PMID 33273784

Citations 2

Authors

Anna T Valson

Manisha Sahay

Narayan Prasad

Sanjay Kumar Agarwal

Santosh Varughese

Sishir Gang

Affiliations

Soon will be listed here.

Citing Articles

Gla-Rich Protein Is Associated with Vascular Calcification, Inflammation, and Mineral Markers in Peritoneal Dialysis Patients.

Marreiros C, Viegas C, Guedes A, Paula Silva A, Aguas A, Faisca M J Clin Med. 2024; 13(23).

PMID: 39685887 PMC: 11642258. DOI: 10.3390/jcm13237429.

Managing chronic kidney disease - mineral bone disorder among patients on maintenance haemodialysis by achieving serum calcium and phosphate targets - a quality improvement project.

Surjit A, Moidu F, Jegan C, Kuruvilla G, Unni V, Philips G Clin Med (Lond). 2024; 23(Suppl 6):123-124.

PMID: 38182231 PMC: 11047045. DOI: 10.7861/clinmed.23-6-s123.

References

Yenchek R, Ix J, Shlipak M, Bauer D, Rianon N, Kritchevsky S . Bone mineral density and fracture risk in older individuals with CKD. Clin J Am Soc Nephrol. 2012; 7(7):1130-6. PMC: 3386677. DOI: 10.2215/CJN.12871211. View

Naylor K, Garg A, Zou G, Langsetmo L, Leslie W, Fraser L . Comparison of fracture risk prediction among individuals with reduced and normal kidney function. Clin J Am Soc Nephrol. 2015; 10(4):646-53. PMC: 4386249. DOI: 10.2215/CJN.06040614. View

West S, Lok C, Langsetmo L, Cheung A, Szabo E, Pearce D . Bone mineral density predicts fractures in chronic kidney disease. J Bone Miner Res. 2014; 30(5):913-9. DOI: 10.1002/jbmr.2406. View

Ball A, Gillen D, Sherrard D, Weiss N, Emerson S, Seliger S . Risk of hip fracture among dialysis and renal transplant recipients. JAMA. 2002; 288(23):3014-8. DOI: 10.1001/jama.288.23.3014. View

Bhatia V . Dietary calcium intake - a critical reappraisal. Indian J Med Res. 2008; 127(3):269-73. View

Sumida K, Ubara Y, Hoshino J, Mise K, Hayami N, Suwabe T . Once-weekly teriparatide in hemodialysis patients with hypoparathyroidism and low bone mass: a prospective study. Osteoporos Int. 2015; 27(4):1441-1450. DOI: 10.1007/s00198-015-3377-6. View

Ketteler M, Block G, Evenepoel P, Fukagawa M, Herzog C, McCann L . Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters. Kidney Int. 2017; 92(1):26-36. DOI: 10.1016/j.kint.2017.04.006. View

Parfrey P, Chertow G, Block G, Correa-Rotter R, Drueke T, Floege J . The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: the EVOLVE trial. J Clin Endocrinol Metab. 2013; 98(12):4834-44. DOI: 10.1210/jc.2013-2975. View

Singh N, Sahni V, Garg D, Nair M . Effect of pharmacological suppression of secondary hyperparathyroidism on cardiovascular hemodynamics in predialysis CKD patients: A preliminary observation. Hemodial Int. 2007; 11(4):417-23. DOI: 10.1111/j.1542-4758.2007.00211.x. View

10.

Vikrant S, Parashar A . Prevalence and severity of disordered mineral metabolism in patients with chronic kidney disease: A study from a tertiary care hospital in India. Indian J Endocrinol Metab. 2016; 20(4):460-7. PMC: 4911834. DOI: 10.4103/2230-8210.183457. View

11.

Isakova T, Xie H, Barchi-Chung A, Smith K, Sowden N, Epstein M . Daily variability in mineral metabolites in CKD and effects of dietary calcium and calcitriol. Clin J Am Soc Nephrol. 2012; 7(5):820-8. PMC: 3338283. DOI: 10.2215/CJN.11721111. View

12.

Oksa A, Spustova V, Krivosikova Z, Gazdikova K, Fedelesova V, Lajdova I . Effects of long-term cholecalciferol supplementation on mineral metabolism and calciotropic hormones in chronic kidney disease. Kidney Blood Press Res. 2008; 31(5):322-9. DOI: 10.1159/000157177. View

13.

Valson A, Sundaram M, David V, Deborah M, Varughese S, Basu G . Profile of incident chronic kidney disease related-mineral bone disorders in chronic kidney disease Stage 4 and 5: A hospital based cross-sectional survey. Indian J Nephrol. 2014; 24(2):97-107. PMC: 3968617. DOI: 10.4103/0971-4065.127897. View

14.

Etta P, Sharma R, Gupta A . Study of chronic kidney disease-mineral bone disorders in newly detected advanced renal failure patients: A Hospital-based cross-sectional study. Saudi J Kidney Dis Transpl. 2017; 28(4):874-885. View

15.

Goswami R, Mishra S, Kochupillai N . Prevalence & potential significance of vitamin D deficiency in Asian Indians. Indian J Med Res. 2008; 127(3):229-38. View

16.

Moe S, Zidehsarai M, Chambers M, Jackman L, Radcliffe J, Trevino L . Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clin J Am Soc Nephrol. 2010; 6(2):257-64. PMC: 3052214. DOI: 10.2215/CJN.05040610. View

17.

Miller P, Roux C, Boonen S, Barton I, Dunlap L, Burgio D . Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials. J Bone Miner Res. 2005; 20(12):2105-15. DOI: 10.1359/JBMR.050817. View

18.

Miller P, Schwartz E, Chen P, Misurski D, Krege J . Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment. Osteoporos Int. 2006; 18(1):59-68. DOI: 10.1007/s00198-006-0189-8. View

19.

Jamal S, Ljunggren O, Stehman-Breen C, Cummings S, McClung M, Goemaere S . Effects of denosumab on fracture and bone mineral density by level of kidney function. J Bone Miner Res. 2011; 26(8):1829-35. DOI: 10.1002/jbmr.403. View

20.

Vautour L, Melton 3rd L, Clarke B, Achenbach S, Oberg A, McCarthy J . Long-term fracture risk following renal transplantation: a population-based study. Osteoporos Int. 2003; 15(2):160-7. DOI: 10.1007/s00198-003-1532-y. View